TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive NCI payline for investigator-initiated R01 grants falls to the 16th percentile, where it’s likely to stay in FY 2006 under the Bush Administration’s budget proposal. March 25, 2005
TCL Archive In Brief: General Motors Cancer Prizes Awarded; Thomas Promoted; HIV Research funding June 24, 1994
